Genome-wide CRISPR screens identify CD48 defining susceptibility to NK cytotoxicity in peripheral T-cell lymphomas.

Genome-wide CRISPR screens identify CD48 defining susceptibility to NK cytotoxicity in peripheral T-cell lymphomas.
复制标题

DOI:
10.1182/blood.2022015646
复制
发表时间:
2022-11-03
期刊:
影响因子:
20.3
通讯作者:
Nakagawa, Masao
Nakagawa, Masao
中科院分区:
医学1区
文献类型:
--
作者:
Chiba, Masahiro;Shimono, Joji;Ishio, Takashi;Takei, Norio;Kasahara, Kohei;Ogasawara, Reiki;Ara, Takahide;Goto, Hideki;Izumiyama, Koh;Otsuguro, Satoko;Perera, Liyanage P.;Hasegawa, Hiroo;Maeda, Michiyuki;Hashino, Satoshi;Maenaka, Katsumi;Teshima, Takanori;Waldmann, Thomas A.;Yang, Yibin;Nakagawa, Masao

文献摘要

参考文献

被引文献

相似文献

成人T细胞白血病/淋巴瘤(ATLL)是一种侵袭性外周T细胞肿瘤,预后差。越来越多的证据表明,逃避适应性免疫是ATLL发病机制的标志。然而,ATLL细胞逃避自然杀伤(NK)细胞介导的免疫的机制知之甚少。在这里,我们表明,CD 48在ATLL细胞的表达决定了NK细胞介导的细胞毒性对ATLL细胞的敏感性。我们使用2种ATLL衍生的细胞系进行了无偏的全基因组成簇规则间隔短回文重复序列(CRISPR)筛选,发现CD 48是最富集的基因之一,其敲除赋予对YT 1-NK细胞系介导的细胞毒性的抗性。使用干扰素-γ(IFNγ)诱导和脱粒减少的人原代NK细胞证实了CD 48敲除ATLL细胞逃避NK细胞效应子功能的能力。我们发现原代ATLL细胞随着疾病进展沿着CD 48表达降低。此外,侵袭性外周T细胞淋巴瘤(PTCL)中的其他亚组也表达较低浓度的CD 48比正常的T细胞,表明CD 48是一个关键的分子在恶性T细胞逃避NK细胞的监视。因此,这项研究表明,CD 48表达可能是恶性T细胞淋巴瘤细胞调节NK细胞介导的免疫至关重要,并提供了一个理论基础,为未来的评价CD 48作为分子生物标志物在NK细胞相关的免疫治疗。全基因组CRISPR文库筛选将CD 48鉴定为定义ATLL中对NK细胞介导的细胞毒性的易感性的关键分子。与正常T细胞相比,ATLL和其他PTCL的CD 48表达减少,这表明CD 48减少在PTCL发病机制中的作用。
Adult T-cell leukemia/lymphoma (ATLL) is one of the aggressive peripheral T-cell neoplasms with a poor prognosis. Accumulating evidence demonstrates that escape from adaptive immunity is a hallmark of ATLL pathogenesis. However, the mechanisms by which ATLL cells evade natural killer (NK)-cell–mediated immunity have been poorly understood. Here we show that CD48 expression in ATLL cells determines the sensitivity for NK-cell–mediated cytotoxicity against ATLL cells. We performed unbiased genome-wide clustered regularly interspaced short palindromic repeat (CRISPR) screening using 2 ATLL-derived cell lines and discovered CD48 as one of the best-enriched genes whose knockout conferred resistance to YT1–NK cell line-mediated cytotoxicity. The ability of CD48-knockout ATLL cells to evade NK-cell effector function was confirmed using human primary NK cells with reduced interferon-γ (IFNγ) induction and degranulation. We found that primary ATLL cells had reduced CD48 expression along with disease progression. Furthermore, other subgroups among aggressive peripheral T-cell lymphomas (PTCLs) also expressed lower concentrations of CD48 than normal T cells, suggesting that CD48 is a key molecule in malignant T-cell evasion of NK-cell surveillance. Thus, this study demonstrates that CD48 expression is likely critical for malignant T-cell lymphoma cell regulation of NK-cell–mediated immunity and provides a rationale for future evaluation of CD48 as a molecular biomarker in NK-cell–associated immunotherapies. Whole-genome CRISPR library screening identified CD48 as a key molecule to define susceptibility to NK-cell–mediated cytotoxicity in ATLL. ATLL and other PTCLs had reduced CD48 expression compared with normal T cells, implicating a role of reduced CD48 in PTCL pathogenesis.
DOI: 10.1182/blood-2013-09-526590
发表时间: 2014-03-06
期刊: Blood
影响因子: 20.3
作者:
Elias S;Yamin R;Golomb L;Tsukerman P;Stanietsky-Kaynan N;Ben-Yehuda D;Mandelboim O
通讯作者: Mandelboim O
DOI: 10.1182/blood-2006-10-055145
发表时间: 2007-06-01
期刊: BLOOD
影响因子: 20.3
作者:
de Leval, Laurence;Rickman, David S.;Gaulard, Philippe
通讯作者: Gaulard, Philippe
DOI: 10.1182/blood-2010-04-277418
发表时间: 2010-12-23
期刊: BLOOD
影响因子: 20.3
作者:
Chen, Jing;Petrus, Mike;Waldmann, Thomas A.
通讯作者: Waldmann, Thomas A.
DOI: 10.1038/s41591-018-0016-8
发表时间: 2018-05
期刊: Nature medicine
影响因子: 82.9
作者:
Chapuy B;Stewart C;Dunford AJ;Kim J;Kamburov A;Redd RA;Lawrence MS;Roemer MGM;Li AJ;Ziepert M;Staiger AM;Wala JA;Ducar MD;Leshchiner I;Rheinbay E;Taylor-Weiner A;Coughlin CA;Hess JM;Pedamallu CS;Livitz D;Rosebrock D;Rosenberg M;Tracy AA;Horn H;van Hummelen P;Feldman AL;Link BK;Novak AJ;Cerhan JR;Habermann TM;Siebert R;Rosenwald A;Thorner AR;Meyerson ML;Golub TR;Beroukhim R;Wulf GG;Ott G;Rodig SJ;Monti S;Neuberg DS;Loeffler M;Pfreundschuh M;Trümper L;Getz G;Shipp MA
通讯作者: Shipp MA
DOI: 10.1182/blood-2005-04-1351
发表时间: 2006-01-01
期刊: BLOOD
影响因子: 20.3
作者:
Bryceson, YT;March, ME;Long, EO
通讯作者: Long, EO